StockData
Mereo BioPharma Group plc logo

Mereo BioPharma Group plc (MREO) stock

MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 1/30
$0.29+0.01 (+5.39%)

Close on Nov 18, 2026Market cap $46.20MP/E –Yield –

Earnings

Mereo BioPharma's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 18, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$800.00K
EPS, Q3 FY2026
-$0.01
-$0.01 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Mereo BioPharma's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 18, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026before the open$800.00K–-$0.01Release
Q2 FY2026ended Jun 30, 2026Aug 11, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 12, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Mar 19, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025during market hours––-$0.01Release
Q2 FY2025ended Jun 30, 2025Aug 12, 2025before the open$500.00K–-$0.02Release
Q1 FY2025ended Mar 31, 2025May 13, 2025before the open––-$0.02Release
Q4 FY2024ended Dec 31, 2024Mar 26, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open––-$0.02Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024before the open––-$0.02Release
Q1 FY2024ended Mar 31, 2024May 15, 2024during market hours––-$0.01Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Mereo BioPharma has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Mereo BioPharma puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Mereo BioPharma filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Results
  6. Update
  7. Update
  8. Update
  9. Results
  10. Results
  11. Results
  12. Results
  13. Update
  14. Results
  15. Results

See a number that looks wrong?